Wall Street Journal  Oct 20  Comment 
The results of the European asset reviews and stress tests are due this weekend. Capital concerns have added to existing reasons to sell bank stocks.
New York Times  Oct 20  Comment 
China is in the midst of a scorching campaign against government corruption, but its system of investigation often operates in secret and beyond the law, leading to abuses suffered by the officials being targeted.
The Hindu Business Line  Oct 19  Comment 
Coffee and pepper cultivation, encouraged in the agency area of Visakhapatnam district (the tribal tracts of Eastern Ghats), has suffered a huge blow as cyclone Hudhud destroyed large stretches of...
TechCrunch  Oct 18  Comment 
 Dear developers: Do you feel insecure because you’re only fluent in a mere eight programming languages used across three families of devices? Does exposure to yet another JavaScript framework make you shudder and wince? Have you postponed a...
SeekingAlpha  Oct 18  Comment 
By Charles Lewis Sizemore, CFA: Aren’t corrections fun? As we suffer through our first real correction, a lot of investors are scared. There is this nagging feeling that the outsized gains of recent years were somehow “fake,” the result of...
Clusterstock  Oct 17  Comment 
Vladimir Putin said Friday that the global economy would collapse if the oil price was allowed to remain at around $80 a barrel for too long. At a press conference following talks on the Ukrainian crisis in Milan, Italy the Russian president...
BusinessWeek  Oct 16  Comment 
Commodities suffer from slumping demand—and the robust U.S. currency
Insurance Journal  Oct 16  Comment 
Dallas County Commissioners will vote today to declare a local state of disaster caused by the Ebola virus. The county “has the potential to suffer widespread or severe damage, injury, loss or threat of life resulting from the Ebola virus,”...
SeekingAlpha  Oct 16  Comment 
By Tedra DeSue: The stock of small cap drug delivery company IntelGenx (OTCQX:IGXT) seemed to be at the cusps of a major breakout earlier this year. Its unique product aimed at treating those who suffer from acute migraine headaches finally seemed...


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki